{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T23:19:18Z","timestamp":1782429558065,"version":"3.54.5"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,24]],"date-time":"2021-08-24T00:00:00Z","timestamp":1629763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,24]],"date-time":"2021-08-24T00:00:00Z","timestamp":1629763200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Cytology and HPV genotype screening play an important role in cervical cancer detection. Whether multiple HPV genotyping can predict cytological lesions remains to be further studied.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Two thousand two hundred twenty-four females were analyzed for cytology and HPV genotypes test. The possibility of predicting cytological lesions by HPV genotypes test was evaluated by multivariate logistic regression and area under the receiver operator characteristic curve (AUC).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Result<\/jats:title>\n                <jats:p>Abnormal cytological results were found in 479 participants. A total of 688 patients were detected with HPV infection, 619 with HR-HPV infection and 112 with LR-HRV infection. HPV-52 was found to be the most common type among these patients, and a relatively higher risk of cervical lesions was found in HPV positive females. HPV-16, 31, 33 and 58 were found to have significantly higher infection rates in patients with HSIL and higher lesions. The prediction model was developed based on age and HPV-specific genotypes, with the AUC of 0.73 for cytological abnormalities and 0.82 for HSIL and higher lesions.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>HPV-16, 31, 33 and 58 infection are significant risk factors for cervical lesions. Combined HPV genotypes test can effectively predict cytological abnormalities.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12885-021-08703-w","type":"journal-article","created":{"date-parts":[[2021,8,24]],"date-time":"2021-08-24T05:04:18Z","timestamp":1629781458000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["HPV-specific risk assessment of cervical cytological abnormalities"],"prefix":"10.1186","volume":"21","author":[{"given":"Guanglei","family":"Zhong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingsheng","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongchun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,24]]},"reference":[{"issue":"4","key":"8703_CR1","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1158\/1055-9965.EPI-16-0858","volume":"26","author":"LA Torre","year":"2017","unstructured":"Torre LA, Islami F, Siegel RL, Ward EM, Jemal A. Global Cancer in women: burden and trends. Cancer Epidemiol Biomark Prev. 2017;26(4):444\u201357. https:\/\/doi.org\/10.1158\/1055-9965.EPI-16-0858.","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"10","key":"8703_CR2","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1002\/ijc.30901","volume":"141","author":"S Vaccarella","year":"2017","unstructured":"Vaccarella S, Laversanne M, Ferlay J, Bray F. Cervical cancer in Africa, Latin America and the Caribbean and Asia: regional inequalities and changing trends. Int J Cancer. 2017;141(10):1997\u20132001. https:\/\/doi.org\/10.1002\/ijc.30901.","journal-title":"Int J Cancer"},{"issue":"9599","key":"8703_CR3","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1016\/S0140-6736(07)61684-5","volume":"370","author":"P Appleby","year":"2007","unstructured":"Appleby P, et al. Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies. Lancet. 2007;370(9599):1609\u201321. https:\/\/doi.org\/10.1016\/S0140-6736(07)61684-5.","journal-title":"Lancet"},{"issue":"11","key":"8703_CR4","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","volume":"11","author":"S de Sanjose","year":"2010","unstructured":"de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol. 2010;11(11):1048\u201356. https:\/\/doi.org\/10.1016\/S1470-2045(10)70230-8.","journal-title":"Lancet Oncol"},{"issue":"7","key":"8703_CR5","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1001\/jama.2018.10897","volume":"320","author":"SJ Curry","year":"2018","unstructured":"Curry SJ, et al. Screening for cervical Cancer: US preventive services task force recommendation statement. Jama. 2018;320(7):674\u201386. https:\/\/doi.org\/10.1001\/jama.2018.10897.","journal-title":"Jama"},{"issue":"3","key":"8703_CR6","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1128\/JCM.00989-09","volume":"48","author":"SS Liu","year":"2010","unstructured":"Liu SS, Leung RCY, Chan KKL, Cheung ANY, Ngan HYS. Evaluation of a newly developed GenoArray human papillomavirus (HPV) genotyping assay and comparison with the Roche linear Array HPV genotyping assay. J Clin Microbiol. 2010;48(3):758\u201364. https:\/\/doi.org\/10.1128\/JCM.00989-09.","journal-title":"J Clin Microbiol"},{"issue":"1","key":"8703_CR7","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","volume":"189","author":"JM Walboomers","year":"1999","unstructured":"Walboomers JM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189(1):12\u20139. https:\/\/doi.org\/10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F.","journal-title":"J Pathol"},{"issue":"10","key":"8703_CR8","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1002\/ijc.27485","volume":"131","author":"P Guan","year":"2012","unstructured":"Guan P, Howell-Jones R, Li N, Bruni L, de Sanjos\u00e9 S, Franceschi S, et al. Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer. Int J Cancer. 2012;131(10):2349\u201359. https:\/\/doi.org\/10.1002\/ijc.27485.","journal-title":"Int J Cancer"},{"issue":"18","key":"8703_CR9","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1093\/jnci\/djr283","volume":"103","author":"HC Chen","year":"2011","unstructured":"Chen HC, Schiffman M, Lin CY, Pan MH, You SL, Chuang LC, et al. Persistence of type-specific human papillomavirus infection and increased long-term risk of cervical cancer. J Natl Cancer Inst. 2011;103(18):1387\u201396. https:\/\/doi.org\/10.1093\/jnci\/djr283.","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"8703_CR10","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1002\/jmv.23719","volume":"86","author":"HS Mbaye el","year":"2014","unstructured":"Mbaye el HS, et al. Human papillomavirus infection in women in four regions of Senegal. J Med Virol. 2014;86(2):248\u201356.","journal-title":"J Med Virol"},{"issue":"2","key":"8703_CR11","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1097\/00007435-200302000-00009","volume":"30","author":"H De Vuyst","year":"2003","unstructured":"De Vuyst H, et al. Distribution of human papillomavirus in a family planning population in Nairobi, Kenya. Sex Transm Dis. 2003;30(2):137\u201342. https:\/\/doi.org\/10.1097\/00007435-200302000-00009.","journal-title":"Sex Transm Dis"},{"issue":"3","key":"8703_CR12","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1097\/OLQ.0b013e31823b50ad","volume":"39","author":"M Dartell","year":"2012","unstructured":"Dartell M, Rasch V, Kahesa C, Mwaiselage J, Ngoma T, Junge J, et al. Human papillomavirus prevalence and type distribution in 3603 HIV-positive and HIV-negative women in the general population of Tanzania: the PROTECT study. Sex Transm Dis. 2012;39(3):201\u20138. https:\/\/doi.org\/10.1097\/OLQ.0b013e31823b50ad.","journal-title":"Sex Transm Dis"},{"issue":"11","key":"8703_CR13","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1002\/jmv.22203","volume":"83","author":"M Rahman","year":"2011","unstructured":"Rahman M, Sasagawa T, Yamada R, Kingoro A, Ichimura H, Makinoda S. High prevalence of intermediate-risk human papillomavirus infection in uterine cervices of Kenyan women infected with human immunodeficiency virus. J Med Virol. 2011;83(11):1988\u201396. https:\/\/doi.org\/10.1002\/jmv.22203.","journal-title":"J Med Virol"},{"issue":"12","key":"8703_CR14","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1086\/657321","volume":"202","author":"L Bruni","year":"2010","unstructured":"Bruni L, Diaz M, Castellsagu\u00e9 X, Ferrer E, Bosch FX, de Sanjos\u00e9 S. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis. 2010;202(12):1789\u201399. https:\/\/doi.org\/10.1086\/657321.","journal-title":"J Infect Dis"},{"issue":"7","key":"8703_CR15","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1056\/NEJM199802123380703","volume":"338","author":"GY Ho","year":"1998","unstructured":"Ho GY, et al. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med. 1998;338(7):423\u20138. https:\/\/doi.org\/10.1056\/NEJM199802123380703.","journal-title":"N Engl J Med"},{"issue":"5","key":"8703_CR16","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/nrc798","volume":"2","author":"H Zur Hausen","year":"2002","unstructured":"Zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer. 2002;2(5):342\u201350.","journal-title":"Nat Rev Cancer"},{"issue":"19","key":"8703_CR17","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1093\/jnci\/djq356","volume":"102","author":"SK Kjaer","year":"2010","unstructured":"Kjaer SK, Frederiksen K, Munk C, Iftner T. Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence. J Natl Cancer Inst. 2010;102(19):1478\u201388. https:\/\/doi.org\/10.1093\/jnci\/djq356.","journal-title":"J Natl Cancer Inst"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-08703-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-021-08703-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-08703-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,24]],"date-time":"2021-08-24T05:04:28Z","timestamp":1629781468000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-021-08703-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,24]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["8703"],"URL":"https:\/\/doi.org\/10.1186\/s12885-021-08703-w","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,24]]},"assertion":[{"value":"24 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All methods were carried out in accordance with relevant guidelines and regulations. The Ethics Committee of Sun Yat-sen Memorial Hospital waived the informed consent, and this research protocol was approved by the Ethics Committee of Sun Yat-sen Memorial Hospital (SYSEC-KY-KS-2020-214).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"There is no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"949"}}